@patrickc@arcinstitute Arc’s Virtual Cell Atlas & Tahoe-100M are extraordinary. Every day, I read headlines about science eradicating disease, yet no treatments exist for my daughter’s de novo 3p25.3 microdeletion, impacting SLC6A1 & HRH1. Could Arc’s single-cell tech offer new insights for cases like hers? Curious where efforts like this might have the most impact.